Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $1.44M invested in Moleculin Biotech in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.01% less ownership
Funds ownership: 14.57% → 10.56% (-4%)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$908K | |
| 2 | +$68.2K | |
| 3 | +$12K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$11.3K |
| 5 |
LPL Financial
San Diego,
California
|
+$4.74K |
Top Sellers
| 1 | -$19.5K | |
| 2 | -$15.2K | |
| 3 | -$4.73K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$70 |
